{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:28:27Z","timestamp":1769923707150,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007546","name":"ANSES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007546","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicaleInstitut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The liver plays a major role in the metabolic activation of xenobiotics (drugs, chemicals such as pollutants, pesticides, food additives...). Among environmental contaminants of concern, heterocyclic aromatic amines (HAA) are xenobiotics classified by IARC as possible or probable carcinogens (2A or 2B). There exist little information about the effect of these HAA in humans. While HAA is a family of more than thirty identified chemicals, the metabolic activation and possible DNA adduct formation have been fully characterized in human liver for only a few of them (MeIQx, PhIP, A<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\alpha$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\"><mml:mi>\u03b1<\/mml:mi><\/mml:math><\/jats:alternatives><\/jats:inline-formula>C).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We have developed a modeling approach in order to predict all the possible metabolites of a xenobiotic and enzymatic profiles that are linked to the production of metabolites able to bind DNA. Our prediction of metabolites approach relies on the construction of an enriched and annotated map of metabolites from an input metabolite.The pipeline assembles reaction prediction tools (SyGMa), sites of metabolism prediction tools (Way2Drug, SOMP and Fame 3), a tool to estimate the ability of a xenobotics to form DNA adducts (XenoSite Reactivity V1), and a filtering procedure based on Bayesian framework. This prediction pipeline was evaluated using caffeine and then applied to HAA. The method was applied to determine enzymes profiles associated with the maximization of metabolites derived from each HAA which are able to bind to DNA. The classification of HAA according to enzymatic profiles was consistent with their chemical structures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Overall, a predictive toxicological model based on an<jats:italic>in silico<\/jats:italic>systems biology approach opens perspectives to estimate the genotoxicity of various chemical classes of environmental contaminants. Moreover, our approach based on enzymes profile determination opens the possibility of predicting various xenobiotics metabolites susceptible to bind to DNA in both normal and physiopathological situations.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12859-021-04363-6","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T04:02:38Z","timestamp":1632196958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Constructing xenobiotic maps of metabolism to predict enzymes catalyzing metabolites capable of binding to DNA"],"prefix":"10.1186","volume":"22","author":[{"given":"Mael","family":"Conan","sequence":"first","affiliation":[]},{"given":"Nathalie","family":"Th\u00e9ret","sequence":"additional","affiliation":[]},{"given":"Sophie","family":"Langouet","sequence":"additional","affiliation":[]},{"given":"Anne","family":"Siegel","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"issue":"1","key":"4363_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1021\/jf072461a","volume":"56","author":"W Ni","year":"2008","unstructured":"Ni W, McNaughton L, LeMaster DM, Sinha R, Turesky RJ. Quantitation of 13 heterocyclic aromatic amines in cooked beef, pork, and chicken by liquid chromatography\u2013electrospray ionization\/tandem mass spectrometry. J Agric Food Chem. 2008;56(1):68\u201378.","journal-title":"J Agric Food Chem"},{"issue":"8","key":"4363_CR2","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1021\/tx200135s","volume":"24","author":"RJ Turesky","year":"2011","unstructured":"Turesky RJ, Le Marchand L. Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol. 2011;24(8):1169\u2013214.","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"4363_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1745-4549.2011.00524.x","volume":"35","author":"F Oz","year":"2011","unstructured":"Oz F, Kaya M. Heterocyclic aromatic amines in meat. J Food Process Preserv. 2011;35(6):739\u201353.","journal-title":"J Food Process Preserv"},{"issue":"2","key":"4363_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/1541-4337.12186","volume":"15","author":"M Gibis","year":"2016","unstructured":"Gibis M. Heterocyclic aromatic amines in cooked meat products: causes, formation, occurrence, and risk assessment. Compr Rev Food Sci Food Saf. 2016;15(2):269\u2013302.","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"4363_CR5","doi-asserted-by":"crossref","unstructured":"Turesky RJ. Chapter 2\u2014Heterocyclic aromatic amines: potential human carcinogens, vol.\u00a04 of Advances in Molecular Toxicology. Elsevier; 2010.","DOI":"10.1007\/978-1-61737-995-6_5"},{"issue":"2\u20133","key":"4363_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/15376510701857320","volume":"18","author":"CA Marchant","year":"2008","unstructured":"Marchant CA, Briggs KA, Long A. In silico tools for sharing data and knowledge on toxicity and metabolism: derek for windows, meteor, and vitic. Toxicol Mech Methods. 2008;18(2\u20133):177\u201387.","journal-title":"Toxicol Mech Methods"},{"key":"4363_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1758-2946-3-18","volume":"3","author":"N Jeliazkova","year":"2011","unstructured":"Jeliazkova N, Jeliazkov V. AMBIT RESTful web services: an implementation of the OpenTox application programming interface. J Cheminform. 2011;3:18.","journal-title":"J Cheminform"},{"issue":"5\u20136","key":"4363_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/10629360802083871","volume":"19","author":"G Patlewicz","year":"2008","unstructured":"Patlewicz G, Jeliazkova N, Safford RJ, Worth AP, Aleksiev B. An evaluation of the implementation of the Cramer classification scheme in the Toxtree software. SAR QSAR Environ Res. 2008;19(5\u20136):495\u2013524.","journal-title":"SAR QSAR Environ Res"},{"key":"4363_CR9","doi-asserted-by":"crossref","unstructured":"Rudik AV, Bezhentsev VM, Dmitriev AV, Druzhilovskiy DS, Lagunin AA, Filimonov DA, et al. MetaTox: web application for predicting structure and toxicity of xenobiotics\u2019 metabolites. J Chem Inf Model. 2017;57(4):638\u201342.","DOI":"10.1021\/acs.jcim.6b00662"},{"issue":"4","key":"4363_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1021\/acs.chemrestox.5b00017","volume":"28","author":"TB Hughes","year":"2015","unstructured":"Hughes TB, Miller GP, Swamidass SJ. Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione. Chem Res Toxicol. 2015;28(4):797\u2013809.","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"4363_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1021\/acscentsci.6b00162","volume":"2","author":"TB Hughes","year":"2016","unstructured":"Hughes TB, Dang NL, Miller GP, Swamidass SJ. Modeling reactivity to biological macromolecules with a deep multitask network. ACS Cent Sci. 2016;2(8):529\u201337.","journal-title":"ACS Cent Sci"},{"issue":"2","key":"4363_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1021\/tx000176e","volume":"14","author":"S Langou\u00ebt","year":"2001","unstructured":"Langou\u00ebt S, Welti DH, Kerriguy N, Fay LB, Huynh-Ba T, Markovic J, et al. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2. Chem Res Toxicol. 2001;14(2):211\u201321.","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"4363_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/carcin\/23.1.115","volume":"23","author":"S Langou\u00ebt","year":"2002","unstructured":"Langou\u00ebt S, Paehler A, Welti DH, Kerriguy N, Guillouzo A, Turesky RJ. Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rat and human hepatocytes. Carcinogenesis. 2002;23(1):115\u201322.","journal-title":"Carcinogenesis"},{"issue":"9","key":"4363_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1021\/tx4002226","volume":"26","author":"G Nauwelaers","year":"2013","unstructured":"Nauwelaers G, Bellamri M, Fessard V, Turesky RJ, Langou\u00ebt S. DNA adducts of the tobacco carcinogens 2-amino-9H-pyrido[2,3-b]indole and 4-aminobiphenyl are formed at environmental exposure levels and persist in human hepatocytes. Chem Res Toxicol. 2013;26(9):1367\u201377.","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"4363_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1021\/acs.chemrestox.6b00394","volume":"30","author":"M Bellamri","year":"2017","unstructured":"Bellamri M, Le Hegarat L, Turesky RJ, Langou\u00ebt S. Metabolism of the tobacco carcinogen 2-Amino-9H-pyrido[2,3-b]indole (A\u03b1C) in primary human hepatocytes. Chem Res Toxicol. 2017;30(2):657\u201368.","journal-title":"Chem Res Toxicol"},{"issue":"22","key":"4363_CR16","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1021\/jm050529c","volume":"48","author":"G Cruciani","year":"2005","unstructured":"Cruciani G, Carosati E, De Boeck B, Ethirajulu K, Mackie C, Howe T, et al. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J Med Chem. 2005;48(22):6970\u20139.","journal-title":"J Med Chem"},{"issue":"6","key":"4363_CR17","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1021\/ci00022a014","volume":"34","author":"G Klopman","year":"1994","unstructured":"Klopman G, Dimayuga M, Talafous JMETA. 1. A program for the evaluation of metabolic transformation of chemicals. J Chem Inf Comput Sci. 1994;34(6):1320\u20135.","journal-title":"J Chem Inf Comput Sci"},{"key":"4363_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12918-015-0241-4","volume":"9","author":"M Yousofshahi","year":"2015","unstructured":"Yousofshahi M, Manteiga S, Wu C, Lee K, Hassoun S. PROXIMAL: a method for prediction of xenobiotic metabolism. BMC Syst Biol. 2015;9:94.","journal-title":"BMC Syst Biol"},{"issue":"11","key":"4363_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2174\/1381612043452596","volume":"10","author":"OG Mekenyan","year":"2004","unstructured":"Mekenyan OG, Dimitrov SD, Pavlov TS, Veith GD. A systematic approach to simulating metabolism in computational toxicology. I. The TIMES heuristic modelling framework. Curr Pharm Des. 2004;10(11):1273\u201393.","journal-title":"Curr Pharm Des"},{"key":"4363_CR20","doi-asserted-by":"crossref","unstructured":"Gao J, Ellis LB, Wackett LP. The University of Minnesota Biocatalysis\/Biodegradation Database: improving public access. Nucleic Acids Res. 2010;38(Database:issue):D488\u201391.","DOI":"10.1093\/nar\/gkp771"},{"issue":"1","key":"4363_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13321-018-0324-5","volume":"11","author":"Y Djoumbou-Feunang","year":"2019","unstructured":"Djoumbou-Feunang Y, Fiamoncini J, Gil-de-la Fuente A, Greiner R, Manach C, Wishart DS. BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification. J Cheminform. 2019;11(1):2.","journal-title":"J Cheminform"},{"issue":"5","key":"4363_CR22","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/cmdc.200700312","volume":"3","author":"L Ridder","year":"2008","unstructured":"Ridder L, Wagener M. SyGMa: combining expert knowledge and empirical scoring in the prediction of metabolites. ChemMedChem. 2008;3(5):821\u201332.","journal-title":"ChemMedChem"},{"issue":"3","key":"4363_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1359-6446(03)02971-4","volume":"9","author":"A Bugrim","year":"2004","unstructured":"Bugrim A, Nikolskaya T, Nikolsky Y. Early prediction of drug metabolism and toxicity: systems biology approach and modeling. Drug Discov Today. 2004;9(3):127\u201335.","journal-title":"Drug Discov Today"},{"issue":"4","key":"4363_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/cmdc.200800384","volume":"4","author":"M Hennemann","year":"2009","unstructured":"Hennemann M, Friedl A, Lobell M, Keldenich J, Hillisch A, Clark T, et al. CypScore: quantitative prediction of reactivity toward cytochromes P450 based on semiempirical molecular orbital theory. ChemMedChem. 2009;4(4):657\u201369.","journal-title":"ChemMedChem"},{"issue":"1","key":"4363_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/03602530600969374","volume":"39","author":"L Afzelius","year":"2007","unstructured":"Afzelius L, Arnby CH, Broo A, Carlsson L, Isaksson C, Jurva U, et al. State-of-the-art tools for computational site of metabolism predictions: comparative analysis, mechanistical insights, and future applications. Drug Metab Rev. 2007;39(1):61\u201386.","journal-title":"Drug Metab Rev"},{"issue":"23","key":"4363_CR26","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1093\/bioinformatics\/btq584","volume":"26","author":"P Rydberg","year":"2010","unstructured":"Rydberg P, Gloriam DE, Olsen L. The SMARTCyp cytochrome P450 metabolism prediction server. Bioinformatics. 2010;26(23):2988\u20139.","journal-title":"Bioinformatics"},{"issue":"3","key":"4363_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/ml100016x","volume":"1","author":"P Rydberg","year":"2010","unstructured":"Rydberg P, Gloriam DE, Zaretzki J, Breneman C, Olsen L. SMARTCyp: a 2D method for prediction of cytochrome P450-mediated drug metabolism. ACS Med Chem Lett. 2010;1(3):96\u2013100.","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"4363_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/acs.jmedchem.7b01552","volume":"61","author":"G Cruciani","year":"2018","unstructured":"Cruciani G, Milani N, Benedetti P, Lepri S, Cesarini L, Baroni M, et al. From experiments to a fast easy-to-use computational methodology to predict human aldehyde oxidase selectivity and metabolic reactions. J Med Chem. 2018;61(1):360\u201371.","journal-title":"J Med Chem"},{"issue":"12","key":"4363_CR29","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1093\/bioinformatics\/btv087","volume":"31","author":"A Rudik","year":"2015","unstructured":"Rudik A, Dmitriev A, Lagunin A, Filimonov D, Poroikov V. SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds. Bioinformatics. 2015;31(12):2046\u20138.","journal-title":"Bioinformatics"},{"issue":"11","key":"4363_CR30","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1021\/ci400503s","volume":"53","author":"J Kirchmair","year":"2013","unstructured":"Kirchmair J, Williamson MJ, Afzal AM, Tyzack JD, Choy AP, Howlett A, et al. FAst MEtabolizer (FAME): a rapid and accurate predictor of sites of metabolism in multiple species by endogenous enzymes. J Chem Inf Model. 2013;53(11):2896\u2013907.","journal-title":"J Chem Inf Model"},{"issue":"8","key":"4363_CR31","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1021\/acs.jcim.9b00376","volume":"59","author":"M \u0160\u00edcho","year":"2019","unstructured":"\u0160\u00edcho M, Stork C, Mazzolari A, de Bruyn Kops C, Pedretti A, Testa B, et al. FAME 3: predicting the sites of metabolism in synthetic compounds and natural products for phase 1 and phase 2 metabolic enzymes. J Chem Inf Model. 2019;59(8):3400\u201312.","journal-title":"J Chem Inf Model"},{"issue":"11","key":"4363_CR32","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1021\/ct200462q","volume":"7","author":"J Li","year":"2011","unstructured":"Li J, Schneebeli ST, Bylund J, Farid R, Friesner RA. IDSite: an accurate approach to predict P450-mediated drug metabolism. J Chem Theory Comput. 2011;7(11):3829\u201345.","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"4363_CR33","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1021\/ci3003073","volume":"52","author":"V Campagna-Slater","year":"2012","unstructured":"Campagna-Slater V, Pottel J, Therrien E, Cantin LD, Moitessier N. Development of a computational tool to rival experts in the prediction of sites of metabolism of xenobiotics by p450s. J Chem Inf Model. 2012;52(9):2471\u201383.","journal-title":"J Chem Inf Model"},{"issue":"3","key":"4363_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1021\/ci7003576","volume":"48","author":"WS Oh","year":"2008","unstructured":"Oh WS, Kim DN, Jung J, Cho KH, No KT. New combined model for the prediction of regioselectivity in cytochrome P450\/3A4 mediated metabolism. J Chem Inf Model. 2008;48(3):591\u2013601.","journal-title":"J Chem Inf Model"},{"issue":"2","key":"4363_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1021\/acs.chemrestox.7b00191","volume":"31","author":"NL Dang","year":"2018","unstructured":"Dang NL, Hughes TB, Miller GP, Swamidass SJ. Computationally assessing the bioactivation of drugs by N-dealkylation. Chem Res Toxicol. 2018;31(2):68\u201380.","journal-title":"Chem Res Toxicol"},{"key":"4363_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.toxlet.2018.10.011","volume":"300","author":"V Delannee","year":"2019","unstructured":"Delannee V, Langou\u00ebt S, Siegel A, Theret N. In silico prediction of heterocyclic aromatic amines metabolism susceptible to form DNA adducts in humans. Toxicol Lett. 2019;300:18\u201330.","journal-title":"Toxicol Lett"},{"key":"4363_CR37","doi-asserted-by":"crossref","unstructured":"Favre HA, Powell WH. Nomenclature of organic chemistry. The Royal Society of Chemistry; 2014.","DOI":"10.1039\/9781849733069"},{"key":"4363_CR38","unstructured":"Daylight Inc., Daylight Theory: SMIRKS\u2014a reaction transform. Language. 2021 https:\/\/www.daylight.com\/dayhtml\/doc\/theory\/theory.smirks.html."},{"issue":"D1","key":"4363_CR39","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47(D1):D1102\u20139.","journal-title":"Nucleic Acids Res"},{"key":"4363_CR40","unstructured":"ChemAxon com. Marvin, . | ChemAxon. 2021. https:\/\/chemaxon.com\/products\/marvin."},{"key":"4363_CR41","doi-asserted-by":"crossref","unstructured":"Jensen FV, Nielsen TD. Bayesian networks and decision graphs. 2nd ed. Springer; 2007.","DOI":"10.1007\/978-0-387-68282-2"},{"key":"4363_CR42","unstructured":"Smith PF, Smith A, Miners J, McNeil J, Proudfoot A. Safety aspects of dietary caffeine-report from the expert working group. Australia New Zealand Food Authority. 2000; p. 20\u20133."},{"issue":"1","key":"4363_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/FPC.0b013e32834c6efd","volume":"22","author":"CF Thorn","year":"2012","unstructured":"Thorn CF, Aklillu E, Klein TE, Altman RB. PharmGKB summary: very important pharmacogene information for CYP1A2. Pharmacogenet Genomics. 2012;22(1):73\u20137.","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"4363_CR44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/1389200211209050667","volume":"13","author":"V Perera","year":"2012","unstructured":"Perera V, Gross AS, McLachlan AJ. Measurement of CYP1A2 activity: a focus on caffeine as a probe. Curr Drug Metab. 2012;13(5):667\u201378.","journal-title":"Curr Drug Metab"},{"issue":"24","key":"4363_CR45","first-page":"5472","volume":"25","author":"MC Cornelis","year":"2016","unstructured":"Cornelis MC, Kacprowski T, Menni C, Gustafsson S, Pivin E, Adamski J, et al. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet. 2016;25(24):5472\u201382.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"4363_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41430-019-0430-0","volume":"74","author":"G Ngueta","year":"2020","unstructured":"Ngueta G. Caffeine and caffeine metabolites in relation to hypertension in U.S. adults. Eur J Clin Nutr. 2020;74(1):77\u201386.","journal-title":"Eur J Clin Nutr"},{"issue":"4","key":"4363_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/cbdd.13445","volume":"93","author":"JD Tyzack","year":"2019","unstructured":"Tyzack JD, Kirchmair J. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery. Chem Biol Drug Des. 2019;93(4):377\u201386.","journal-title":"Chem Biol Drug Des"},{"issue":"9","key":"4363_CR48","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1007\/s00204-017-1935-8","volume":"91","author":"M Chevereau","year":"2017","unstructured":"Chevereau M, Glatt H, Zalko D, Cravedi JP, Audebert M. Role of human sulfotransferase 1A1 and N-acetyltransferase 2 in the metabolic activation of 16 heterocyclic amines and related heterocyclics to genotoxicants in recombinant V79 cells. Arch Toxicol. 2017;91(9):3175\u201384.","journal-title":"Arch Toxicol"},{"issue":"7216","key":"4363_CR49","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"R McLendon","year":"2008","unstructured":"McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061\u20138.","journal-title":"Nature"},{"key":"4363_CR50","doi-asserted-by":"crossref","unstructured":"The GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318\u201330.","DOI":"10.1126\/science.aaz1776"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-021-04363-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-021-04363-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T03:14:17Z","timestamp":1699499657000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-021-04363-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4363"],"URL":"https:\/\/doi.org\/10.1186\/s12859-021-04363-6","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"assertion":[{"value":"27 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"450"}}